Aldeyra The (ALDX) vs INmune Bio, Inc. (INMB)
A side-by-side comparison of Aldeyra The and INmune Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALDX
Aldeyra The
$0.96HealthcareDelayed quote: Oct 6, 2026, 10:34 AM EDT
INMB
INmune Bio, Inc.
$1.91HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
Total return — ALDX vs INMB
growth of $100 · dividends reinvested · last 8yALDX -89.7% (-24.8%/yr)INMB -75.7% (-16.2%/yr)INMB compounded faster over this window
ALDX INMB
ALDX vs INMB: by the numbers
- •ALDX is the larger company ($58M vs $51M market cap).
- •Both run net losses; ALDX's is the smaller (0.00% vs -91866.00% net margin).
Metrics side by side
Valuation
| Metric | ALDX | INMB |
|---|---|---|
| P/B ratio | 1.53 | 2.49 |
Profitability
| Metric | ALDX | INMB |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -61738.00% |
| Net margin | 0.00% | -91866.00% |
| ROE | -60.85% | -90.44% |
| ROIC | -63.52% | -96.37% |
Growth (annualized)
| Metric | ALDX | INMB |
|---|---|---|
| Total return CAGR (5Y) | -36.54% | -36.88% |
Frequently asked
- How have ALDX and INMB total returns compared?
- Over the past 5 years, ALDX delivered -36.54% and INMB delivered -36.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.